Hainan Haiyao Signs LOI for Stake in SinoMab BioScience Ltd.  
11/14/2012 1:22:07 PM

by Richard Daverman, PhD

November 14, 2012 -- Hainan Haiyao Co. signed a letter of intent to acquire a 40% stake in SinoMab Bioscience Limited, a company that is headquartered in Hong Kong with offices and manufacturing facilities in Shenzhen. Established in 2001, SinoMab is seeking to discover therapeutic antibodies that treat life-threatening and debilitating diseases. Terms of the proposed transaction were not disclosed. More details....

Stock Symbol: (SHE: 000566)